Innovotech Inc IOT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CAD 0.12
- Day Range
- CAD 0.10–0.10
- 52-Week Range
- CAD 0.06–0.15
- Bid/Ask
- CAD 0.05 / CAD 0.16
- Market Cap
- CAD 3.89 Mil
- Volume/Avg
- 6,000 / 4,869
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 3.62
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Innovotech Inc is a Canada-based company that provides solutions to client biofilm problems through its biofilm contract research department. The core activities of the company are sales of its products, conducting contract research for outside customers, and research and development to identify products for future commercialization. The products of the company include human and fungal biofilm susceptibility tests, a seed treatment designed to combat bacterial and fungal diseases, and an assay used in growing microbial biofilms for research purposes. Geographically, the firm has its business presence in the United States, Canada, and other countries of which the majority of the revenue is derived from the United States.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 14
- Website
- https://www.innovotech.ca
Valuation
|
Metric
|
IOT
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 5.01 |
Price/Sales | 3.62 |
Price/Cash Flow | — |
Price/Earnings
IOT
Financial Strength
|
Metric
|
IOT
|
|---|---|
Quick Ratio | 5.53 |
Current Ratio | 6.59 |
Interest Coverage | −190.21 |
Quick Ratio
IOT
Profitability
|
Metric
|
IOT
|
|---|---|
Return on Assets (Normalized) | −19.16% |
Return on Equity (Normalized) | −25.43% |
Return on Invested Capital (Normalized) | −21.65% |
Return on Assets
IOT
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Kympvtjmr | Sfmh | $578.5 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Zbfgmbz | Dvkgj | $101.5 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Srnknvtyt | Jpkmx | $98.1 Bil | |
MRNA
| Moderna Inc | Vpzyqcm | Vpqmn | $42.2 Bil | |
ARGX
| argenx SE ADR | Hmgdfwm | Bzfbb | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Wrczkyxg | Hryh | $21.4 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Ncrxbsf | Jdzhq | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Qfkmdnvy | Smcqgf | $15.3 Bil | |
RPRX
| Royalty Pharma PLC Class A | Xzbnwrnds | Gtkhfzh | $12.5 Bil | |
INCY
| Incyte Corp | Rqsbjmld | Zlpslcc | $11.7 Bil |